Laryngitis Clinical Trials

Find Laryngitis Clinical Trials Near You

Alginate vs Sucralfate for GERD Symptomatic Relief in Combination With PPIS

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY

Gastroesophageal reflux disease (GERD) is a chronic gastrointestinal disorder characterized by the regurgitation of gastric contents into the esophagus.It can also present in an atypical manner such as chest pain, dental erosions, chronic cough, laryngitis, or asthma i.e. extra gastroesophageal symptoms. Sucralfate is a unique anti-ulcer drug and is a basic aluminum salt of sucrose octa-sulfate. It forms a protective layer, enhancing bicarbonate production, demonstrating anti-peptic properties, and fostering tissue growth, regeneration, and repair and it undergoes minimal enteral reabsorption. Alginate is a naturally occurring anionic polymer typically obtained from brown seaweed and has been extensively investigated and used for many biomedical applications, due to its biocompatibility, low toxicity, relatively low cost, and mild gelation by addition of divalent cations such as Ca2+.Both sucralfate and alginate have been in use for the treatment and symptomatic relief of GERD and are well tolerated oral formulations.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: f
View:

• All patients having symptoms of severe GERD for more than 3 times /week

Locations
Other Locations
Pakistan
Cmh Lahore
RECRUITING
Lahore
Contact Information
Primary
Muhammad N Nasir, MBBS
nabeelnasir2004@live.com
00923454500293
Backup
Muhammad Hafeez
00923338555260
Time Frame
Start Date: 2025-04-01
Estimated Completion Date: 2026-02-28
Participants
Target number of participants: 140
Treatments
Experimental: Alginate Group
Patient meeting the eligibility criteria will be given two tablespoons before meal twice a day along with PPIS.
Active_comparator: Sucralfate Group
Patient meeting the eligibility criteria will be given two tablespoons before meal twice a day along with PPIS.
Sponsors
Leads: CMH Lahore Medical College and Institute of Dentistry

This content was sourced from clinicaltrials.gov